Anhui Meiluo Pharmaceutical Technology Co., Ltd., formerly known as Changzhou Audi Chemical Technology Co., Ltd., is a technology-driven enterprise dedicated to the research and development of pharmaceutical intermediates, particularly specializing in the customization and production of fluorinated heterocyclic pharmaceutical intermediates. To better serve its customers, the company established Anhui Meiluo Pharmaceutical Technology Co., Ltd. in 2021 at the Ningma Science and Technology Innovation Park in Cihu High-Tech Zone, Ma'anshan, Anhui Province, where it built a 2,600-square-meter R&D center.

The company boasts a team of young, excellent, cohesive, and creative professionals, including doctors and masters with years of experience in organic synthesis, as well as well-trained chemical technicians. It has also collaborated with pharmaceutical and chemical enterprises in Shijiazhuang, Xuchang, and Yantai to establish pilot and scale-up workshops. The company specializes in various types of reactions such as halogenation, hydrogenation, nitration, condensation, oxidation, and reduction. It maintains strong technical collaborations with East China Normal University, Changzhou University, and the School of Pharmacy of Wannan Medical College, demonstrating robust capabilities in new product development.

The company has provided over a thousand customized compounds for its clients, primarily supplying major pharmaceutical and pesticide manufacturers, as well as research institutions both domestically and internationally. Its products are exported to the United States, Europe, Japan, India, and other countries and regions. The company can offer customized production ranging from small-scale laboratory gram-level synthesis to commercial ton-scale manufacturing based on customer needs.